The New Zealand dental journal 2012-12-01

Common medications among dental outpatients: considerations in general dental practice.

Nicholas I Cutfield, Darryl C Tong

文献索引:N. Z. Dent. J. 108(4) , 140-7, (2012)

全文:HTML全文

摘要

To provide information about the most common medications listed as being taken by dental patients presenting to an outpatient setting at a tertiary institution and to establish a list of the most common medications for review for the general dental practitioner.A retrospective review was undertaken of 300 dental outpatient notes chosen from patients seen in the urgent dental care and exodontia clinics at the School of Dentistry in Dunedin. Data were recorded on patient age, medication list reported at the time of presentation and the number of medications. The ten most common medications encountered were listed in order of frequency, along with the ten most common prescription medications and the most common supplements or alternative remedies. A concise pharmacological synopsis for each of the ten most common medications was then presented as a review.The age range of patients was from 18 to 88 years, with a mean age of 43.2 years (median age 41 years). More than one-quarter were aged 20-29 years. Some 56% of patients reported taking at least one medication at the time of presentation. The greatest number of medications being taken by an individual patient was 15. Of 138 different medications identified, the most commonly reported included aspirin, paracetamol and omeprazole. A list of the ten most common medications was established for concise review, in order to outline aspects important to the general dental practitioner.This study provides information on the most common medications reported among dental outpatients presenting to a tertiary institution and highlights the need for general dental practitioners to be knowledgeable about them and their impact on dental treatment.


相关化合物

  • 奥美拉唑
  • 西拉普利
  • (1S,9S)-9-{[(2R)-...

相关文献:

Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.

2015-10-01

[Drug Metab. Dispos. 43 , 1408-16, (2015)]

HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.

2015-01-01

[Arch. Pharm. Res. 38 , 691-704, (2015)]

Evaluation of the effect of TM208 on the activity of five cytochrome P450 enzymes using on-line solid-phase extraction HPLC-DAD: a cocktail approach.

2013-04-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 923-924 , 29-36, (2013)]

Effects of Polygonum multiflorum on the activity of cytochrome P450 isoforms in rats.

2015-01-01

[Pharmazie 70(1) , 47-54, (2015)]

Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.

1999-09-24

[Anal. Bioanal. Chem 406(18) , 4453-64, (2014)]

更多文献...